| TEMPUS AI INC. DL-,01 |
| USA |
| Gesundheit |
| US88023B1035 / A40EDP |
| F3M (Frankfurt) / TEM (NASDAQ) |
| FRA:F3M, ETR:F3M, F3M:GR, NASDAQ:TEM |
| - |
| https://www.tempus.com/ |
|
Tempus AI, Inc. is a healthcare technology company that applies artificial intelligence and machine learning to advance precision medicine. It builds platforms and provides next-generation diagnostics across key areas including oncology, neuropsychia..
>Volltext.. |
| 7091.12 Mio. EUR |
| 7679.47 Mio. EUR |
| 1174.19 Mio. EUR |
| -127.08 Mio. EUR |
| -260.73 Mio. EUR |
| -1.47 EUR |
| 1134.91 Mio. EUR |
| 448.59 Mio. EUR |
| - |
| 2.01 |
| 59.01% |
| 60% |
| - |
| - |
| - |
| 6 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 11.194.931 USD. |
| TEMPUS AI, TEMPUS AI′S, TEMPUS AI S |
| 22.05.26 |